Pekka Suhonen

742 total citations
24 papers, 609 citations indexed

About

Pekka Suhonen is a scholar working on Molecular Biology, Pharmaceutical Science and Pharmacology. According to data from OpenAlex, Pekka Suhonen has authored 24 papers receiving a total of 609 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 7 papers in Pharmaceutical Science and 5 papers in Pharmacology. Recurrent topics in Pekka Suhonen's work include Advanced Drug Delivery Systems (5 papers), Drug Transport and Resistance Mechanisms (3 papers) and Phytochemistry and Biological Activities (3 papers). Pekka Suhonen is often cited by papers focused on Advanced Drug Delivery Systems (5 papers), Drug Transport and Resistance Mechanisms (3 papers) and Phytochemistry and Biological Activities (3 papers). Pekka Suhonen collaborates with scholars based in Finland. Pekka Suhonen's co-authors include Arto Urtti, Tomi Järvinen, Veli‐Pekka Ranta, Elisa Toropainen, Pekka Peura, Hannu Kokki, Seppo Auriola, David W. Pate, Pekka Jarho and Mirka Laavola and has published in prestigious journals such as Journal of Chromatography A, International Journal of Pharmaceutics and Pharmaceutical Research.

In The Last Decade

Pekka Suhonen

23 papers receiving 592 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Pekka Suhonen Finland 14 226 217 124 92 76 24 609
Ravinder Earla United States 13 137 0.6× 162 0.7× 99 0.8× 58 0.6× 88 1.2× 18 516
Michael C. Makoid United States 11 159 0.7× 115 0.5× 178 1.4× 66 0.7× 174 2.3× 26 517
Thomas J. Mikkelson United States 12 160 0.7× 122 0.6× 148 1.2× 15 0.2× 88 1.2× 15 511
Diane Tang‐Liu United States 15 192 0.8× 163 0.8× 312 2.5× 183 2.0× 341 4.5× 34 826
Sukhbir S. Chrai United States 7 354 1.6× 161 0.7× 375 3.0× 132 1.4× 355 4.7× 7 806
James W. Sieg United States 8 256 1.1× 111 0.5× 180 1.5× 30 0.3× 141 1.9× 9 419
J. R. Deverre France 15 88 0.4× 231 1.1× 23 0.2× 86 0.9× 26 0.3× 25 535
Laura Rabinovich‐Guilatt United States 10 123 0.5× 101 0.5× 70 0.6× 36 0.4× 21 0.3× 33 369
Mayssa Attar United States 13 76 0.3× 158 0.7× 188 1.5× 351 3.8× 566 7.4× 34 971
Xiaohui Jiang United States 12 235 1.0× 153 0.7× 23 0.2× 29 0.3× 7 0.1× 29 777

Countries citing papers authored by Pekka Suhonen

Since Specialization
Citations

This map shows the geographic impact of Pekka Suhonen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pekka Suhonen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pekka Suhonen more than expected).

Fields of papers citing papers by Pekka Suhonen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pekka Suhonen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pekka Suhonen. The network helps show where Pekka Suhonen may publish in the future.

Co-authorship network of co-authors of Pekka Suhonen

This figure shows the co-authorship network connecting the top 25 collaborators of Pekka Suhonen. A scholar is included among the top collaborators of Pekka Suhonen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pekka Suhonen. Pekka Suhonen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kokki, Hannu, et al.. (2004). Pharmacokinetics of Oxycodone After Intravenous, Buccal, Intramuscular and Gastric Administration in Children. Clinical Pharmacokinetics. 43(9). 613–622. 53 indexed citations
2.
Urtti, Arto, Elisa Toropainen, Veli‐Pekka Ranta, et al.. (2003). Paracellular and Transcellular Permeability in Human Corneal Epithelial Cell Culture Model. Investigative Ophthalmology & Visual Science. 44(13). 3453–3453. 3 indexed citations
3.
Kokki, Hannu, et al.. (2003). Pharmacokinetics of Intravenous and Rectal Ketoprofen in Young Children. Clinical Pharmacokinetics. 42(4). 373–379. 19 indexed citations
4.
Toropainen, Elisa, Veli‐Pekka Ranta, Kati‐Sisko Vellonen, et al.. (2003). Paracellular and passive transcellular permeability in immortalized human corneal epithelial cell culture model. European Journal of Pharmaceutical Sciences. 20(1). 99–106. 83 indexed citations
5.
Ruponen, Marika, et al.. (2002). Extracellular and intracellular factors influencing gene transfection mediated by 1,4-dihydropyridine amphiphiles. European Journal of Pharmaceutical Sciences. 15(5). 449–460. 28 indexed citations
6.
Suhonen, Pekka, et al.. (1998). Different effects of pH on the permeation of pilocarpine and pilocarpine prodrugs across the isolated rabbit cornea. European Journal of Pharmaceutical Sciences. 6(3). 169–176. 21 indexed citations
7.
Järvinen, Tomi, et al.. (1996). Amphiphilic properties of pilocarpine prodrugs. International Journal of Pharmaceutics. 133(1-2). 171–178. 16 indexed citations
8.
Jarho, Pekka, Arto Urtti, David W. Pate, Pekka Suhonen, & Tomi Järvinen. (1996). Increase in aqueous solubility, stability and in vitro corneal permeability of anandamide by hydroxypropyl-β-cyclodextrin. International Journal of Pharmaceutics. 137(2). 209–216. 49 indexed citations
9.
Suhonen, Pekka, et al.. (1996). Rate control of ocular pilocarpine delivery with bispilocarpic acid diesters. International Journal of Pharmaceutics. 127(1). 85–94. 8 indexed citations
10.
Suhonen, Pekka, et al.. (1995). Ocular Absorption and Irritation of Pilocarpine Prodrug Is Modified with Buffer, Polymer, and Cyclodextrin in the Eyedrop. Pharmaceutical Research. 12(4). 529–533. 50 indexed citations
11.
Järvinen, Tomi, et al.. (1995). Comparison of Enzymatic Hydrolysis of Pilocarpine Prodrugs in Human Plasma, Rabbit Cornea, and Butyrylcholinesterase Solutions. Journal of Pharmaceutical Sciences. 84(5). 656–660. 18 indexed citations
12.
Järvinen, Tomi, Pekka Suhonen, Seppo Auriola, et al.. (1992). Bispilocarpic acid monoesters as prodrugs of pilocarpine: I. Preparation and identification. International Journal of Pharmaceutics. 79(1-3). 233–242. 5 indexed citations
13.
Suhonen, Pekka, et al.. (1992). Synthesis and analysis of O,O′-dicarboxylate (dibenzyl) bispilocarpates as possible prodrugs of pilocarpine. Journal of Pharmaceutical and Biomedical Analysis. 10(2-3). 153–161. 5 indexed citations
14.
Peura, Pekka, et al.. (1991). Synthesis and identification of pilocarpic acid diesters, prodrugs of pilocarpine. Journal of Pharmaceutical and Biomedical Analysis. 9(6). 457–464. 12 indexed citations
15.
Suhonen, Pekka, et al.. (1991). Improved Corneal Pilocarpine Permeability with O,O′-(l,4-Xylylene) Bispilocarpic Acid Ester Double Prodrugs. Pharmaceutical Research. 8(12). 1539–1542. 21 indexed citations
16.
Suhonen, Pekka, Tomi Järvinen, Pekka Peura, & Arto Urtti. (1991). Permeability of pilocarpic acid diesters across albino rabbit cornea in vitro. International Journal of Pharmaceutics. 74(2-3). 221–228. 30 indexed citations
17.
Järvinen, Tomi, et al.. (1991). Determination of physicochemical properties, stability in aqueous solutions and serum hydrolysis of pilocarpic acid diesters. Journal of Pharmaceutical and Biomedical Analysis. 9(9). 737–745. 10 indexed citations
18.
Ylinen, Markku, Pekka Suhonen, Toivo Naaranlahti, Seppo Lapinjoki, & Aarre Huhtikangas. (1990). Gas chromatographic-mass spectrometric analysis of major indole alkaloids of Catharanthus roseus. Journal of Chromatography A. 505(2). 429–434. 8 indexed citations
19.
Suhonen, Pekka, et al.. (1972). Alvar Aalto luonnoksia. 1 indexed citations
20.
Suhonen, Pekka, et al.. (1970). Palava omaisuus. Books Abroad. 44(1). 159–159.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026